Our Companies

Biomedical Science Consulting Company, BioSciCon, Inc., is a woman-owned, small business start-up biotechnology company focused on R&D of the proprietary MarkPap® technology. BioSciCon has recently organized a consortium of business companies to commercialize the MarkPap® technology as new products emerge from the R&D component after translational research from prototypes to products. The other members of this consortium are MarkPap LLC with mission to commercialize the MarkPap technology and MarkPap Pacific LLC, with limited scope of commercialization of the technology in the emerging economies of China, India and other countries in the wider Pacific region.
All companies are located in Rockville, MD. BioSciCon headquarters are at Forest Landing Circle, Rockville, MD. Another BioSciCon' facility is at the Johns Hopkins University, Montgomery County Campus, Rockville, MD. MarkPap Pacific LLC is located at the Shady Grove Innovation Center in Rockville, MD. The Global Academy for Women's Health, Inc is located at the John's Hopkins University, Montgomery County Campus in Rockville, MD. Please see Contact Us page for details.

The potential members of the consortium are Ricca Chemical Company, Arlington, TX which is currently manufacturing the MarkPap Kit, Kemp Biotechnologies, Frederick, MD and GT-Vision, Hagerstown, MD.

In 2007, BioSciCon sponsored the creation of The Global Academy for Women's Health, Inc., independent non-profit organization which integrated the multiple prior non-profit activities of BioSciCon's founders continuing their legacy to work for public benefit improving women's health and saving women's lives.

Our Mission

The primary mission of BioSciCon, Inc. is to bring the new MarkPap® Technology products to public benefit and save women's lives around the world. The primary function of MarkPap LLC is to commercialize proprietary MarkPap® Technology products after completion of the translational research, and to provide resources for further financing of R&D

Who We Are

The Founding Director of BioSciCon is Olivera Markovic, M.D., Ph.D. She is also the President of The Global Academy for Women's Health, Inc. Dr. Markovic is an experienced, NIH trained cancer research scientist, university/medical school professor and author. She taught students at all levels, from undergraduate to doctoral and postdoctoral level. Dr. Olivera Markovic has published more then 180 scientific publications, including books, chapters, invited review articles and patents. She has been a Principal Investigator of research projects funded by the NIH, industry, universities and private foundations. Dr. Markovic has also managerial skills being a director of clinical laboratory departments and research laboratories. Featured in bibliographical records of Marquis Who's Who in the World, Who's Who in America, Who's Who in Science and Engineering, Who's Who in Medicine and Healthcare and Who's Who of American Women. She was selected among 2000 Outstanding People of the 20th Century by the International Bibliographical Centre, Cambridge, England.

The President of BioSciCon, MarkPap LLC and MarkPap Pacific LLC is Nenad Markovic, M.D., Ph.D.
Dr. Nenad Markovic is an entrepreneur by his own decision, not by his vocation, education or professional experience. The reason why this high ranking academician (chair of oncology, full professor of medicine and hematology, professor of laboratory medicine and clinical pharmacology), successful medical doctor (head, chief and director of clinical units and departments), recipient of many recognitions and awards for excellence in medicine and allied sciences, and renown cancer research scientist (author of four books and 200 scientific papers, trained and participated in the medical programs at NIH and FDA), has decided to become an entrepreneur was the discovery made by him and Dr. Olivera Markovic of a new bioactive protein residing only in specimens obtained from abnormal cervical tissues, and the success of this team of scientists to develop a proprietary method for visualization of this protein by simple laboratory pathology means.

The idea was conceived in 1987, the small business company formed in 1996, preclinical studies completed to enable the issuance of the patent for a new product covering the protein, the methods for its visualization and the application – clinical use as an in vitro diagnostic in 2000. Since this time, they planned a long term translational research to develop products which, based on the original principles, will help billions of women in need for protection against a grave disease. One direction of this translational research is coming to the final milestone – generation of medical services for tangible revenue. This is the idea about the IT Telehealth Center as the end step succeeding prior accomplishments named IT Telehealth System, MarkPap Digital Telecytopathology Workstation, etc. – long way back to the original idea and its pluri-potential ability for development of needed medical devices and procedures.

Ms. Jane Jing is Vice President for China Affairs at MarkPap Pacific, LLC. She is graduate of Finance and Economics from Tianjin University, PR China and MBA from Oklahoma City University, USA. Prior to joining MarkPap Pacific LLC in 2008, she was a Business Banking Officer at City Bank NA in Washington DC, and AVP, Business Relation Manager at HSBC USA in Rockville, MD. She is bringing to the Company her financial and business expertise as well as knowledge on business issues in PR China. She is fluent in English and Chinese languages.

Oleg Panashchenko, Ph.D. is the Chief Information Technology Officer at MarkPap Pacific, LLC. He holds MS degree in Physics and PhD degree in Optical Physics from Moscow Institute of Physics and Technology. Dr. Panashchenko is bringing to the Company his exceptional talents and vast experience in comprehensive software development and information technology experience. He successfully served in all aspects of software development life-cycle including design,development, implementation and support for Java/J2EE, C++ and mixed language systems for standard, web-based and enterprise-level applications. Prior to joining MarkPap Pacific, Dr. Panashchenko worked for USPTO, Lockheed Martin, Tachyon Networks Planet Exchange, Inc, International Land Systems, Inc, in the US and Tavex and Lucky Net, Kiev, Ukraine.

BioSciCon Cervical Cancer Study Group is a multidisciplinary research group consisting of medical doctors (general practitioners, gynecologists, oncologists and pathologists) from BioSciCon's Clinical and Laboratory Research Sites, and oncologists, biomedical scientists, statisticians, chemists, physicists, computer scientists, and experts in other disciplines affiliated with this program who participate in the BioSciCon's Research Site. Currently active members of the group are highlighted with asterisk. This is a dynamic group of professional teams that are perpetually changing depending on actual programs. Nenad Markovic, MD, PhD* (Research Center), Olivera Markovic, MD, PhD* (Research Center), Lewis Townsend, MD* (Clinical Site), William Smith, MD* (Laboratory Site), James Sundeen, MD (Laboratory Site), David Hankins, PhD* (Laboratory Site), Vladan Posarac, MD (Research Center), Mr. Stephen McJonathan* (Microscopy/Imaging), Oleg Panashchenko, PhD* (optical physicist and computer scientist, Research Center), Mr. Derrick Miller (IT/Web), Gary Peck, MD* (Scientific Consultant), Edward Henderson, MD* (Scientific Consultant), S. Kati, PhD* (statistician, Research Center), Ing. Marjan Cotic* (IT Consultant), Ing. Cvetan Saljinski* (Imaging/Photography Consultant), Shelly Parr, MD (Clinical Site), Jonathan Cosin, MD (Clinical Site), MIlena Simic (Research Center), Allan Ross, MD (Clinical Site), Venkat Iyer, MD (Laboratory Site). Members of this group serve on the Scientific Board per a particular program. Dr. Olivera Markovic coordinates Scientific Board activities.

Business Advisory Team. Counselors to Small Businesses, Chapter 1, Washington, DC provides continuous business support through the Lead Counselor, Ms. Ann Dobbs and other counselors from the Chapter contributing with their particular expertise. BioSciCon, Inc was SCORE Client of the Year in 2005. MarkPap Pacific LLC is a resident client of the Shady Grove Innovation Center in Rockville MD and is provided with legal and business development support within the Montgomery County Incubators Network. Moawad and Herischi Law firm from Chevy Chase, MD provides legal services. Mr. Duc Duong is an Advisor for China market helping MarkPap Pacific LLC. Ms. Jane Jing, VP for China Project. BioSciCon, Inc. is a Corporate Partner of the Johns Hopkins University, Montgomery County Campus. Business professionals constitute The MarkPap LLC Business Development Team, which is coordinated by Dr. Nenad Markovic, President and CEO of MarkPap LLC.

Acknowledgements

MarkPap Technology development has been supported in part by SBIR phases 1 and 2 grants from the National Institutes of Health, Bethesda, MD. NIH also provided business development support through the NIH Commercialization Assistance Program (CAP 2006/2007) to foster further commercialization of BioSciCon products. Information about BioSciCon, Inc. and MarkPap® Technology appears on the NIH Web Site, Office of Technology Transfer and SBIR and STTR Success Story for BioSciCon, Inc.
Department for Economic Development, Montgomery County, MD provided a grant/loan to BioSciCon in the past.